Paclitaxel Injection bulk supplier for pharma manufacturers

Paclitaxel Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, 500 mg/83.3 mL

Reference Brands: Taxol(US & EU)

Paclitaxel Injection (30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, and 500 mg/83.3 mL) is a chemotherapy drug used to treat cancers like breast cancer, ovarian cancer, and non-small cell lung cancer (NSCLC). Available in both the U.S. and EU, it works by inhibiting cancer cell division through IV infusion. A key product for oncology B2B distribution, it is essential for effective cancer treatment in hospitals and oncology centers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Paclitaxel Injection 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, and 500 mg/83.3 mL is a vital chemotherapy drug used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and other cancers. Approved in both the U.S. and EU, Paclitaxel is administered via IV infusion and acts by disrupting microtubule formation, inhibiting cancer cell division. Available in various strengths, it is a cornerstone drug for oncology centers and hospitals. This makes it a key product in oncology B2B distribution, ensuring effective cancer treatment for a wide range of malignancies.

Paclitaxel Injection — third party manufacturing & bulk supply

Paclitaxel Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Paclitaxel Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Paclitaxel Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Paclitaxel Injection →

Back to Listing

Frequently Asked Questions

Paclitaxel Injection is listed as Injection in 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, 500 mg/83.3 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Paclitaxel Injection is referenced against Taxol(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.